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Although long term use of cyclooxygenase (COX)-2 inhibitors may be asso-
ciated with increased cardiovascular risk, their effects on vascular reactivity in
atherosclerosis has remained largely unexplored. The aim of the present study
was to evaluate the role of COX-2 induced by an atherosclerotic process, in the
local control of vascular tone. To this end, New Zealand White rabbits were fed
0.3% cholesterol for 3 weeks before being subjected to balloon injury of the
abdominal aorta. After another 2 weeks, the aorta was removed and used for
organ bath experiments and immunohistochemistry, and the prostaglandins
released were measured using enzyme immunoassays. Hypercholesterolemia
and vascular injury significantly increased the thickness of the intimal layer,
which was associated with an induction of COX-2 immunoreactivity throughout
the aortic wall. In these preparations, a significant decrease of the maximal con-
tractions induced by norepinephrine was observed: 89.3±12 mN in controls
(n=5) versus 67.6±13 mN in balloon injured aortas from hypercholesterolemic
rabbits (n=5); P<0,05. The norepinephrine-induced contractions of atheroscle-
rotic preparations were restored by the COX inhibitors DuP-697 (0.5 μmol/L)
and indomethacin (1.7 μmol/L), to similar contractions as was observed in aortic
preparations derived from healthy rabbits. Norepinephrine stimulation of the
abdominal aorta was accompanied by increased levels of prostaglandin I2 in ath-
erosclerotic (1,39±0,11 μg/mg, n=3) compared with normal aorta (0,53±0,17 μg/
mg, n=3, P<0,05). Selective COX-2 inhibition significantly decreased the pros-
taglandin I2 release from atherosclerotic aorta, but had no effect on the prostag-
landin release from aortic preparations derived from normal rabbits. These
observations suggest that the local induction of COX-2 during atherosclerosis
decreased the sensitivity to norepinephrine, and that COX-2 inhibitors may
locally increase vascular reactivity at sites of atherosclerotic lesions.
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Background: Paraoxonase (PON1), an enzyme closely associated with
high-density lipoproteins, appears to exert an important antioxidant effect by
removing lipid peroxidation products. PON1 may also play a role in the
pathogenesis of arterial thrombosis and atherosclerosis. The PON1 gene poly-
morphism involves a Gln → Arg interchange at codon 192 defined by a low-
activity isoform (Q allele) and a high-activity isoform (R allele) and has been
related in some studies to myocardial infarction (MI). The purpose of the
present study was to assess the relationship between PON1-192 polymor-
phism, and myocardial infarction in Tunisian population.
Material and method: A total of 303 Tunisian patients with MI and 408
healthy controls were included in the study. Diagnosis of MI was confirmed
according to the European Society of Cardiology criteria. The PON1-Q192R
genotypes were determined by polymerase chain reaction (PCR) amplification
and restriction analysis.
Results: The genotypes frequencies were in agreement with those pre-
dicted by the Hardy-Weinberg equilibrium in MI patients (X2=5.52;p=0.63)
and controls (X2=4.126; p=0.127). A significant difference in genotype distri-
bution and allele frequency was observed between patients and controls.
Patients with MI had a frequency of 17.1 % for RR genotype, 41.1% for the
QR genotype and 41.7% for the QQ genotype. The controls had a frequency
of only 10.9% for the RR genotype, 37.4% for the QR genotype and 51.6 %
for the RR genotype (X2=9.63, p=0.008). The MI patient group showed a sig-
nificantly higher frequency of R allele compared to controls (37.75%
vs. 29.55%; X2=10.74; p<0.001). In comparison to the QQ homozygotes, the
OR (95%CI) for MI was 1.35 (0.992-1.86) for QR heterozygotes and 1.93
(1.24-3.02) for RR homozygotes. In multivariate analysis, PON1-Q192R poly-
morphism is associated with MI (p=0.02). The other factors independently
associated with MI are age (p<0.001), cigarette smoking (p<0.001), hyper-
tension (p<0.02), diabetes mellitus (p<0.001) and dyslipidemia (p<0.01).
Conclusion: Our results show that PON1-192 polymorphism is indepen-
dently associated with myocardial infarction in our population.
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The aim of this study was to investigate the potential effect of chronic admin-
istration of N-acetylcysteine (NAC), a thiol drug with antioxidant properties, on
the coronary endothelial dysfunction associated with LVH. Twenty-two 8-week-
old Landrace male swine were randomly divided into 4 experimental groups. The
control group (group 1) was submitted to a thoracotomy without aortic banding
(AB). The untreated aortic banded group (group 2) was kept for 60 days. The first
AB treated group (group 3) received 1000mg/day of NAC per os for 60 days
starting on the day of the surgery. The second AB treated group (group
4) received the same oral dose of NAC for 30 days starting on day 30. Hyper-
trophy was assessed by echocardiography. Coronary vascular reactivity was eval-
uated in organ chambers. Nitrite/nitrate ratio and glutathione levels were measured
to evaluate endothelial dysfunction. Finally, to assess oxidative stress, plasma lipid
hydroperoxide levels (LPO) were measured. The LV mass/ left ventricular dias-
tolic diameter ratio was significantly higher in group 2 (37.6±10.0 g/cm) compared
to group 1 (16.4±1.5 g/cm) confirming the development of LVH. This latest was
found to be associated with a significant endothelial dysfunction (maximal relax-
ation to serotonin 76±2% versus 85±3% for group 1 and 2 respectively; maximal
relaxation to bradykinin 100±0% versus 96±1% for group 1 and 2, respectively).
NAC did not prevent LVH development in group 3 (30.5±2.3 g/cm; p>0.05 versus
group 2) but attenuated its progression in group 4 (25.4±3.0 g/cm). Concentration
response curves to NAC showed improvement in endothelium-dependent relax-
ation to serotonin (55±2% and 57±3% for group 3 and 4, respectively) and to
bradykinin (99±1% and 99±1%). LPO levels were significantly lower in both
treated group as compared to group 2 (p<0.05). Both nitrite/nitrate ratio and glu-
tathione levels were significantly higher in both NAC treated groups compared to
group 2 (p<0.05). NAC supplementation demonstrated potent antioxidant proper-
ties in this porcine LVH model and may become a promising approach for the pre-
vention of coronary endothelial dysfunction.
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We wondered if Zucker obese (ZO) rats would be a good experimental
model to evaluate cardiovascular complications of Metabolic Syndrome (MS).
ZO rats were compared with both their littermate controls, Zucker lean (ZL) rats
and to Wistar rats (reference strain). We designed this work 1) to measure cer-
tain physical and biochemical characteristics of MS 2) to evaluate coronary and
cardiac function in isolated conditions and after ischemia 3) to study plasma and
heart tissue oxidative stress markers. In vivo, ZO rats had higher levels of
plasma glucose, cholesterol and triglycerides than their ZL littermates, but there
was no difference between the groups for systolic arterial blood pressure and
heart rate. In vitro, coronary endothelial function was notably impaired in ZO
and ZL rats. After global ischemia, the worse ventricular recovery in ZO and ZL
rats was associated with arrhythmias during reperfusion. We detected similar
levels of plasma ascorbyl free radical, Oxygen Radical Absorbance Capacity and
